GYNETICS HOPES TO HAVE EMERGENCY CONTRACEPTIVE PILLS ON MARKET BY 1998
The reproductive research firm Gynetics hopes to have an emergency contraceptive product on the market by 1998, the company said following FDA's request for NDAs for use of oral contraceptives for post-coital contraception.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth